Lepu Medical Technology (Beijing) Co., Ltd.
300003
Classement en actions
#4746
Established in 1999 and headquartered in Beijing, China, Lepu Medical... Established in 1999 and headquartered in Beijing, China, Lepu Medical Technology is a prominent company dedicated to the research, development, production, and sale of a broad spectrum of medical devices, pharmaceuticals, and healthcare services. The company's extensive medical device portfolio primarily focuses on cardiovascular health. This includes interventional cardiology products such as coronary stents, balloons, catheters, guide wires, and related PCI accessories. It also provides solutions for structural heart diseases, like occluders, vascular plugs, delivery systems, and mechanical heart valves. Lepu Medical offers cardiac rhythm management products, including pacemakers, equipment, leads, and electrophysiology systems, alongside products for off-pump coronary artery bypass grafting and peripheral interventional devices such as PTA balloons and guide wires. Beyond cardiovascular applications, their offerings extend to critical care products like vascular access devices, needle-free connectors, blood samplers, and pressure transducers. The company also provides digital subtraction angiography (DSA) systems (both floor and suspended types), in vitro diagnostic (IVD) equipment and biomarkers, hemodialysis catheters and hollow fiber dialyzers, and general surgery instruments including surgical staplers and endo surgery accessories. In the pharmaceutical sector, Lepu Medical manufactures and distributes medications for various conditions. This encompasses a comprehensive range of cardiovascular drugs designed to treat issues like thrombosis, hyperlipidemia, hypertension, angina, and heart failure. Additionally, they produce beta-lactamase antibiotics and antifungal antimicrobial drugs, central nervous system medications (such as painkillers and antidepressants), treatments for gastric/duodenal ulcers and chronic liver disease, respiratory system drugs, hypoproteinemia drugs, and agents that activate blood circulation. Furthermore, Lepu Medical provides a diverse array of healthcare services. These include precision medicine, remote ECG telemonitoring, and specialized consulting and management centers for cardiovascular diseases. The company is also involved in medical science and technology incubation, equity investment, and offers medical financial services. Its service offerings extend to general health consultation, online pharmacy platforms, sales of household medical equipment, smart medical devices, and the operation of specialized hospitals focusing on cardiovascular care. Lepu Medical actively participates in the establishment and co-construction of cardiac catheterization laboratories (Cath Labs).
Prix de l'action
$1.78
Capitalisation boursière
$3.15B
Changement (1 jour)
6.19%
Changement (1 an)
-30.01%
Pays
CN
Échange Lepu Medical Technology (Beijing) Co., Ltd. (300003)
Catégorie
Healthcare
Ratio P/E pour Lepu Medical Technology (Beijing) Co., Ltd. (300003)
Ratio P/E au October 2026 TTM : 26.94
Selon les derniers rapports financiers et le cours de l'action de Lepu Medical Technology (Beijing) Co., Ltd., le ratio P/E actuel (TTM) est de 26.94. À la fin de l’année 2023, le P/E de l’entreprise était de 23.68.
Historique du ratio P/E pour Lepu Medical Technology (Beijing) Co., Ltd. de 2006 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 26.94 | -68.26% |
| 2024 | 84.88 | 258.42% |
| 2023 | 23.68 | 26.07% |
| 2022 | 18.78 | -20.35% |
| 2021 | 23.58 | -12.01% |
| 2020 | 26.80 | -21.04% |
| 2019 | 33.94 | 15.62% |
| 2018 | 29.36 | -36.13% |
| 2017 | 45.97 | 0.31% |
| 2016 | 45.82 | -23.84% |
| 2015 | 60.16 | 31.75% |
| 2014 | 45.66 | 21.35% |
| 2013 | 37.63 | 104.00% |
| 2012 | 18.45 | -21.43% |
| 2011 | 23.48 | -56.69% |
| 2010 | 54.20 | -17.55% |
| 2009 | 65.74 | -42.79% |
| 2008 | 114.92 | -10.24% |
| 2007 | 128.03 | 5.55% |
| 2006 | 121.29 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 33.11 | 22.91% |
US
|
|
| 21.39 | -20.61% |
IE
|
|
| 28.94 | 7.45% |
US
|
|
| 17.34 | -35.64% |
US
|
|
| - | - |
DE
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.